BJDX Bluejay Diagnostics, Inc.
Healthcare$1.93+0.52%ClosedMarket Cap: $875,334
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.21
P/S
0.00
EV/EBITDA
0.40
DCF Value
$10.79
FCF Yield
-763.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-144.3%
ROA
-123.3%
ROIC
-163.5%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-1.9M | $-1.9M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-1.5M | $-1.4M | $— | — |
| FY null | $0.00 | NaN% | $-7.0M | $-6.8M | $— | — |
| Q3 null | $0.00 | NaN% | $-1.6M | $-1.6M | $— | — |
| Q2 null | $0.00 | NaN% | $-2.0M | $-2.0M | $— | — |
| Q1 null | $0.00 | NaN% | $-1.9M | $-1.9M | $— | — |
| Q4 null | $0.00 | NaN% | $-1.5M | $-1.4M | $— | — |
| FY null | $0.00 | NaN% | $-7.2M | $-7.7M | $— | — |
| Q3 null | $0.00 | NaN% | $-1.4M | $-1.5M | $— | — |
| Q2 null | $0.00 | NaN% | $-1.9M | $-2.5M | $— | — |
| Q1 null | $0.00 | NaN% | $-2.4M | $-2.3M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-2.4M | $-2.3M | $-59.48 | — |